US Treasury Targets Tax Avoiding Corporate Inversion Deals

The US Treasury has announced new efforts to curb international tax avoidance measures known as corporate inversions. 

The new rules have cast doubt on a proposed $160 billion deal between pharmaceutical companies Pfizer and Allergan. 

From Washington, Daniel Ryntjes reports...

IN: The new package...

OUT: SOC

DUR: 35"

AIR: http://fsnradionews.com/feeds/0405inversion-dr-air.mp3

ARN: http://fsnradionews.com/feeds/0405inversion-dr-arn.mp3

FM4: http://fsnradionews.com/feeds/0405inversion-dr-fm4.mp3

GEN: http://fsnradionews.com/feeds/0405inversion-dr-generic.mp3

ICRT: http://fsnradionews.com/feeds/0405inversion-dr-icrt.mp3

RNZ: http://fsnradionews.com/feeds/0405inversion-dr-rnz.mp3

SABC: http://fsnradionews.com/feeds/0405inversion-dr-sabc.mp3

SRN: http://fsnradionews.com/feeds/0405inversion-dr-srn.mp3

VATICAN: http://fsnradionews.com/feeds/0405inversion-dr-vat.mp3

VON: http://fsnradionews.com/feeds/0405inversion-dr-von.mp3

ZIZ: http://fsnradionews.com/feeds/0405inversion-dr-ziz.mp3

938: http://fsnradionews.com/feeds/0405inversion-dr-938.mp3